1
Broekman, K Esther, van der Aa, Maaike A, Nijman, Hans W, Jalving, Mathilde, Reyners, Anna K L
Veröffentlicht in: Broekman , K E , van der Aa , M A , Nijman , H W , Jalving , M & Reyners , A K L 2022 , ' End-of-life care for patients with advanced ovarian cancer in the Netherlands : A retrospective registry-based analysis ' , Gynecologic Oncology , vol. 166 , no. 1 , pp. 148-153 . https://doi.org/10.1016/j.ygyno.2022.04.017;
2022
Veröffentlicht in: Broekman , K E , van der Aa , M A , Nijman , H W , Jalving , M & Reyners , A K L 2022 , ' End-of-life care for patients with advanced ovarian cancer in the Netherlands : A retrospective registry-based analysis ' , Gynecologic Oncology , vol. 166 , no. 1 , pp. 148-153 . https://doi.org/10.1016/j.ygyno.2022.04.017;
2022
2
3
Eggen, Annemarie C., Hospers, Geke A. P., Bosma, Ingeborg, Kramer, Miranda C. A., Reyners, Anna K. L., Jalving, Mathilde
Veröffentlicht in: Eggen , A C , Hospers , G A P , Bosma , I , Kramer , M C A , Reyners , A K L & Jalving , M 2022 , ' Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases ' , BMC Cancer , vol. 22 , no. 1 , 247 . https://doi.org/10.1186/s12885-022-09316-7;
2022
Veröffentlicht in: Eggen , A C , Hospers , G A P , Bosma , I , Kramer , M C A , Reyners , A K L & Jalving , M 2022 , ' Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases ' , BMC Cancer , vol. 22 , no. 1 , 247 . https://doi.org/10.1186/s12885-022-09316-7;
2022
4
de Haan-Du, Jing, Groenier, Klaas H., Wauben-Spaetgens, Brendy, Jalving, Mathilde, Kleefstra, Nanne, Landman, Gijs W.D., de Bock, Geertruida H.
Veröffentlicht in: de Haan-Du , J , Groenier , K H , Wauben-Spaetgens , B , Jalving , M , Kleefstra , N , Landman , G W D & de Bock , G H 2023 , ' The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care ' , Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology , vol. 32 , no. 2 , pp. 252-259 . https://doi.org/10.1158/1055-9965.EPI-22-0766;
2023
Veröffentlicht in: de Haan-Du , J , Groenier , K H , Wauben-Spaetgens , B , Jalving , M , Kleefstra , N , Landman , G W D & de Bock , G H 2023 , ' The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care ' , Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology , vol. 32 , no. 2 , pp. 252-259 . https://doi.org/10.1158/1055-9965.EPI-22-0766;
2023
5
Bisschop, Cornelis, Wind, Thijs T, Blank, Christian U, Koornstra, Rutger H T, Kapiteijn, Ellen, Van den Eertwegh, Alfonsus J M, De Groot, Jan Willem B, Jalving, Mathilde, Hospers, Geke A P
Veröffentlicht in: Bisschop , C , Wind , T T , Blank , C U , Koornstra , R H T , Kapiteijn , E , Van den Eertwegh , A J M , De Groot , J W B , Jalving , M & Hospers , G A P 2019 , ' Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma : Results From the Dutch Expanded Access Program ' , Journal of Immunotherapy , vol. 42 , no. 6 , pp. 208-214 . https://doi.org/10.1097/CJI.0000000000000271;
2019
Veröffentlicht in: Bisschop , C , Wind , T T , Blank , C U , Koornstra , R H T , Kapiteijn , E , Van den Eertwegh , A J M , De Groot , J W B , Jalving , M & Hospers , G A P 2019 , ' Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma : Results From the Dutch Expanded Access Program ' , Journal of Immunotherapy , vol. 42 , no. 6 , pp. 208-214 . https://doi.org/10.1097/CJI.0000000000000271;
2019
6
Levy, Sonja, Aarts, Maureen J. B., Eskens, Ferry A. L. M., Keymeulen, Kristien B. M., Been, Lukas B., Grunhagen, Dirk, van Akkooi, Alexander, Jalving, Mathilde, Tesselaar, Margot E. T.
Veröffentlicht in: Levy , S , Aarts , M J B , Eskens , F A L M , Keymeulen , K B M , Been , L B , Grunhagen , D , van Akkooi , A , Jalving , M & Tesselaar , M E T 2020 , ' Avelumab for advanced Merkel cell carcinoma in the Netherlands : a real-world cohort ' , Journal for ImmunoTherapy of Cancer , vol. 8 , no. 2 , 001076 . https://doi.org/10.1136/jitc-2020-001076;
2020
Veröffentlicht in: Levy , S , Aarts , M J B , Eskens , F A L M , Keymeulen , K B M , Been , L B , Grunhagen , D , van Akkooi , A , Jalving , M & Tesselaar , M E T 2020 , ' Avelumab for advanced Merkel cell carcinoma in the Netherlands : a real-world cohort ' , Journal for ImmunoTherapy of Cancer , vol. 8 , no. 2 , 001076 . https://doi.org/10.1136/jitc-2020-001076;
2020
7
Levy, Sonja, Aarts, Maureen J.B., Eskens, Ferry A.L.M., Keymeulen, Kristien B.M.I., Been, Lukas B., Grunhagen, Dirk, Van Akkooi, Alexander, Jalving, Mathilde, Tesselaar, Margot E.T.
Veröffentlicht in: Levy , S , Aarts , M J B , Eskens , F A L M , Keymeulen , K B M I , Been , L B , Grunhagen , D , Van Akkooi , A , Jalving , M & Tesselaar , M E T 2020 , ' Avelumab for advanced Merkel cell carcinoma in the Netherlands : A real-world cohort ' , Journal for immunotherapy of cancer , vol. 8 , no. 2 , e001076 . https://doi.org/10.1136/jitc-2020-001076;
2020
Veröffentlicht in: Levy , S , Aarts , M J B , Eskens , F A L M , Keymeulen , K B M I , Been , L B , Grunhagen , D , Van Akkooi , A , Jalving , M & Tesselaar , M E T 2020 , ' Avelumab for advanced Merkel cell carcinoma in the Netherlands : A real-world cohort ' , Journal for immunotherapy of cancer , vol. 8 , no. 2 , e001076 . https://doi.org/10.1136/jitc-2020-001076;
2020
8